FIELD: medicine.
SUBSTANCE: invention refers to using a compound of formula (I)
or its pharmaceutically acceptable salt in producing a medicinal agent for treating or preventing inflammatory ophthalmic diseases by inducing macrophage activation regulation and a T-lymphocyte mediated response in the eye. In formula (I) n equals to 6; A means CH2O; R means H or CH3. The invention also refers to the method of treating or preventing an inflammatory ophthalmic disease.
EFFECT: higher efficacy of using the compound.
15 cl, 10 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE UVEITIS | 1996 |
|
RU2107480C1 |
| USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
| USE OF FORMYL PEPTIDE RECEPTOR 2 AGONISTS FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2768730C2 |
| METHOD OF TREATMENT OF EYE INFLAMMATORY DISEASES AND AGENT FOR TREATMENT OF EYE INFLAMMATORY DISEASES | 1992 |
|
RU2048812C1 |
| NEUTRAL ENDOPEPTIDASE (NEP) AND SOLUBLE HUMAN ENDOPEPTIDASE (SHE) INHIBITORS FOR PREVENTION AND TREATMENT OF EYE DISEASES | 2019 |
|
RU2758771C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS, AND A METHOD FOR USE THEREOF | 2018 |
|
RU2694226C1 |
| CYCLOSPORINE DERIVATIVES FOR TREATING OPHTHALMIC AND SKIN DISEASES AND CONDITIONS | 2009 |
|
RU2521358C2 |
| PREPARATION "GISTOKHROM" FOR TREATMENT OF EYE RETINA AND CORNEA INFLAMMATORY SICKNESSES | 1998 |
|
RU2134107C1 |
| PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATORY CYTOKINES | 2019 |
|
RU2816868C2 |
| ANTI-INFLAMMATORY AND MYDRIATIC INTRA-CHAMBER SOLUTIONS FOR INHIBITION OF POSTOPERATIVE INFLAMMATORY EYE CONDITIONS | 2015 |
|
RU2750296C2 |
